J&J hit with $966M jury award in Los Angeles over talc-related cancer case

Johnson & Johnson (NYSE:JNJ) will have to pay $966M after a jury in Los Angeles issued a verdict in favor of a woman who claimed that the pharma giant’s talc-based baby powder caused her to develop a rare cancer called

Leave a Reply

Your email address will not be published. Required fields are marked *